RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.

In a report released on January 29, Jack Lynch from RBC Capital maintained a Hold rating on HUB24 Limited (FSB – Research Report), with a price ...

US stocks slipped on Friday afternoon, with carmakers and Chinese companies leading the decline, as the White House said ...

UBS analyst Susy Tibaldi updated the financial outlook for EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), increasing the price ...

Australian shares are poised to rise with inflation data awaited. Boeing surged, Nvidia rebounded and Apple extended its recovery. Follow updates here.

Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his ...

RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, ...

On Friday, Exelixis Inc (EXEL) stock saw a decline, ending the day at $32.38 which represents a decrease of $-1.75 or -5.13% from the prior close of $34.13. The stock opened at $33.49 and touched a ...

UBS upgraded British American Tobacco on Monday ... to buy the shares and make it a more attractive "pure-play", RBC Capital Markets said in a note on Monday. WH Smith confirmed earlier that ...

HSBC is preparing to wind down its M&A and equity capital markets businesses in Europe, the UK and the Americas as part of a ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

What is the outlook of the Colgate Palmolive stock price ahead of earnings? We explain whether it may drop soon ...